[{"Assets_0_Q2_USD":7646945000.0,"CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q2_USD":20.08,"EarningsPerShareBasic_2_Q2_USD":49.12,"EarningsPerShareDiluted_1_Q2_USD":19.86,"EarningsPerShareDiluted_2_Q2_USD":48.6,"Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":198345000.0,"NetIncomeLossConverted_1_Q2_USD":598810000.0,"NetIncomeLossConverted_2_Q2_USD":1464005000.0,"OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q2_USD":572619000.0,"RevenuesConverted_2_Q2_USD":1126598000.0,"SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q2_USD":5486810000.0,"Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":30154000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":30125000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29814000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29807000.0,"filed":"20190806","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2019.0","name":"BIO-RAD LABORATORIES, INC.","period":"20190630","qtrs":"0","uom":"USD"}]